window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events

    Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development

    Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development

    $2.5M awarded to fuel breakthrough research into tau-driven neurodegenerative diseases

    The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business

    Atelerix appoints new chair and non-executive director to board

    Atelerix, a Newcastle-based biotech specialising in hydrogel encapsulation for cell [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Manufacturing & Supply Chain,Therapeutic Areas

    Nanexa extends feasibility agreement with major pharma company for long-acting formulation study

    The collaboration, Nanexa says, provides further proof that PharmaShell atomic [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    Citi Pharma joins forces with Chinese firm to boost antibiotic production in Pakistan

    Citi Pharma has partnered with Xin Weisheng to build an [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events,Therapeutic Areas

    Sidra Medicine awarded $100K G-Rex grant for CAR-T manufacturing platform

    ScaleReady has awarded a $100,000 G-Rex grant to Sidra Medicine, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development

    Revolo moves oral formulation of allergy drug into development following preclinical boost

    Revolo Biotherapeutics says it is accelerating plans to bring a [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Opinion & Events

    Ethris begins Phase 2a trial of intranasal mRNA candidate ETH47 for virus-triggered asthma

    Ethris has dosed the first patient in a Phase 2a [...]

    May 5, 2026
  • Advanced Therapies,Therapeutic Areas

    Broken String renews NIST gene editing safety push with INDUCE-seq technology

    Broken String Biosciences has reaffirmed its commitment to supporting the [...]

    May 5, 2026
Previous171819Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Lonza licenses dual-payload ADC technology to Antharis for GI cancers
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Grifols launches Fesilty in US for congenital fibrinogen deficiency
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE recommends pirtobrutinib for relapsed chronic lymphocytic leukaemia
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top